Association between fibrinogen and fibrinogen γ' and atherosclerotic plaque morphology and composition in symptomatic carotid artery stenosis: Plaque-At-RISK study.
Atherosclerosis
Computed tomography angiography
Fibrinogen
Magnetic resonance imaging
Stroke
von Willebrand factor
Journal
Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
02
10
2018
revised:
16
01
2019
accepted:
23
02
2019
pubmed:
22
3
2019
medline:
7
1
2020
entrez:
22
3
2019
Statut:
ppublish
Résumé
Von Willebrand Factor (VWF), ADAMTS13, fibrinogen and fibrinogen γ' are associated with an increased risk of ischemic stroke. Carotid atherosclerosis is an important risk factor for ischemic stroke. Characteristics of the vulnerable plaque; intraplaque hemorrhage (IPH), plaque ulceration and lipid-rich necrotic core (LRNC) can be visualized with imaging techniques. Since atherosclerosis might attribute to the association between coagulation factors and ischemic stroke risk, the aim of this study is to investigate the association between coagulation factors and atherosclerotic plaque characteristics in more detail. In 182 patients of the Plaque-At-RISK study (prospective multicenter cohort study) with a recent transient ischemic attack (TIA) or ischemic stroke and a symptomatic mild-to-moderate carotid artery stenosis, we measured VWF antigen (VWF:Ag), ADAMTS13 activity, fibrinogen (Clauss), and fibrinogen γ'. Presence of plaque ulceration, IPH volume and LRNC volume were determined by Multidetector-Row Computed Tomography (MDCTA, n = 160) and Magnetic Resonance Imaging (MRI, n = 172). Linear regression analysis was used to assess the association between imaging biomarkers and coagulation factors. VWF:Ag or ADAMTS13 levels were not significantly associated with plaque ulceration, IPH and LRNC. We found an inverse association between fibrinogen and fibrinogen γ' and IPH volume (B = -23.40 mm Fibrinogen and fibrinogen γ' are inversely associated with IPH volume and LRNC volume, independent of inflammation. clinicaltrials.govNCT01208025.
Identifiants
pubmed: 30897531
pii: S0049-3848(19)30075-1
doi: 10.1016/j.thromres.2019.02.030
pii:
doi:
Substances chimiques
Fibrinogens, Abnormal
0
fibrinogen gamma'
0
Fibrinogen
9001-32-5
Banques de données
ClinicalTrials.gov
['NCT01208025']
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
130-135Informations de copyright
Copyright © 2019. Published by Elsevier Ltd.